Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 112

1.

Persistence of use of prescribed cannabinoid medicines in Manitoba, Canada: a population-based cohort study.

Alkabbani W, Marrie RA, Bugden S, Alessi-Severini S, Bolton JM, Daeninck P, Leong C.

Addiction. 2019 Jun 25. doi: 10.1111/add.14719. [Epub ahead of print]

PMID:
31240747
2.

Risk and associated factors for a future schizophrenia diagnosis after an index diagnosis of unspecified psychotic disorder: A population-based study.

Hensel JM, Chartier MJ, Ekuma O, MacWilliam L, Mota N, Tachere RO, McDougall C, Bolton JM.

J Psychiatr Res. 2019 Jul;114:105-112. doi: 10.1016/j.jpsychires.2019.04.019. Epub 2019 Apr 22.

PMID:
31059990
3.

An evaluation of large group cognitive behaviour therapy with mindfulness (CBTm) classes.

Thakur VK, Wong JY, Randall JR, Bolton JM, Parikh SV, Mota N, Whitney D, Palay J, Kinley J, Diocee S, Sala T, Sareen J.

BMC Psychiatry. 2019 May 3;19(1):132. doi: 10.1186/s12888-019-2124-5.

4.

Gender differences in information needs and preferences regarding depression among individuals with multiple sclerosis, inflammatory bowel disease and rheumatoid arthritis.

Marrie RA, Walker JR, Graff LA, Patten SB, Bolton JM, Marriott JJ, Fisk JD, Hitchon C, Peschken C, Bernstein CN; CIHR Team in Defining the Burden and Managing the Effects of Immune-mediated Inflammatory Disease.

Patient Educ Couns. 2019 Apr 6. pii: S0738-3991(19)30132-6. doi: 10.1016/j.pec.2019.04.007. [Epub ahead of print]

5.

Mental Disorders and Suicide Attempts in the Pregnancy and Postpartum Periods Compared with Non-Pregnancy: A Population-Based Study.

Mota NP, Chartier M, Ekuma O, Nie Y, Hensel JM, MacWilliam L, McDougall C, Vigod S, Bolton JM.

Can J Psychiatry. 2019 Jul;64(7):482-491. doi: 10.1177/0706743719838784. Epub 2019 Mar 20.

PMID:
30895808
6.

The Prevalence and Risk Factors of Undiagnosed Depression and Anxiety Disorders Among Patients With Inflammatory Bowel Disease.

Lewis K, Marrie RA, Bernstein CN, Graff LA, Patten SB, Sareen J, Fisk JD, Bolton JM; CIHR Team in Defining the Burden and Managing the Effects of Immune-Mediated Inflammatory Disease .

Inflamm Bowel Dis. 2019 Mar 19. pii: izz045. doi: 10.1093/ibd/izz045. [Epub ahead of print]

PMID:
30888037
7.

Ambivalence About Living and the Risk for Future Suicide Attempts: A Longitudinal Analysis.

Naherniak B, Bhaskaran J, Sareen J, Wang Y, Bolton JM.

Prim Care Companion CNS Disord. 2019 Mar 7;21(2). pii: 18m02361. doi: 10.4088/PCC.18m02361.

8.

Comorbid anxiety, depression, and cognition in MS and other immune-mediated disorders.

Whitehouse CE, Fisk JD, Bernstein CN, Berrigan LI, Bolton JM, Graff LA, Hitchon CA, Marriott JJ, Peschken CA, Sareen J, Walker JR, Stewart SH, Marrie RA; CIHR Team in Defining the Burden and Managing the Effects of Psychiatric Comorbidity in Chronic Immunoinflammatory Disease.

Neurology. 2019 Jan 11. pii: 10.1212/WNL.0000000000006854. doi: 10.1212/WNL.0000000000006854. [Epub ahead of print]

PMID:
30635487
9.

Suicide and all-cause mortality in a high-risk cohort: A latent class approach.

Randall JR, Sareen J, Bolton JM.

Gen Hosp Psychiatry. 2018 Nov 22. pii: S0163-8343(18)30076-8. doi: 10.1016/j.genhosppsych.2018.11.004. [Epub ahead of print]

PMID:
30529067
10.

Diabetes and anxiety adversely affect cognition in multiple sclerosis.

Marrie RA, Patel R, Figley CR, Kornelsen J, Bolton JM, Graff L, Mazerolle EL, Marriott JJ, Bernstein CN, Fisk JD; Comorbidity and Cognition in Multiple Sclerosis (CCOMS) Study Group.

Mult Scler Relat Disord. 2019 Jan;27:164-170. doi: 10.1016/j.msard.2018.10.018. Epub 2018 Oct 23.

11.

Adverse psychiatric effects of disease-modifying therapies in multiple Sclerosis: A systematic review.

Gasim M, Bernstein CN, Graff LA, Patten SB, El-Gabalawy R, Sareen J, Bolton JM, Marriott JJ, Fisk JD, Marrie RA; CIHR team “Defining the burden and managing the effects of psychiatric comorbidity in chronic inflammatory disease”.

Mult Scler Relat Disord. 2018 Nov;26:124-156. doi: 10.1016/j.msard.2018.09.008. Epub 2018 Sep 12.

12.

Factors associated with perceived need for mental health care in multiple sclerosis.

Orr J, Bernstein CN, Graff LA, Patten SB, Bolton JM, Sareen J, Marriott JJ, Fisk JD, Marrie RA; CIHR Team in Defining the Burden and Managing the Effects of Immune-mediated Inflammatory Disease.

Mult Scler Relat Disord. 2018 Oct;25:179-185. doi: 10.1016/j.msard.2018.07.043. Epub 2018 Jul 29.

13.

Increased Burden of Psychiatric Disorders in Inflammatory Bowel Disease.

Bernstein CN, Hitchon CA, Walld R, Bolton JM, Sareen J, Walker JR, Graff LA, Patten SB, Singer A, Lix LM, El-Gabalawy R, Katz A, Fisk JD, Marrie RA; CIHR Team in Defining the Burden and Managing the Effects of Psychiatric Comorbidity in Chronic Immunoinflammatory Disease.

Inflamm Bowel Dis. 2019 Jan 10;25(2):360-368. doi: 10.1093/ibd/izy235.

PMID:
29986021
14.

Psychiatric comorbidity increases mortality in immune-mediated inflammatory diseases.

Marrie RA, Walld R, Bolton JM, Sareen J, Patten SB, Singer A, Lix LM, Hitchon CA, El-Gabalawy R, Katz A, Fisk JD, Bernstein CN; CIHR Team in Defining the Burden and Managing the Effects of Psychiatric Comorbidity in Chronic Immunoinflammatory Disease.

Gen Hosp Psychiatry. 2018 Jul - Aug;53:65-72. doi: 10.1016/j.genhosppsych.2018.06.001. Epub 2018 Jun 7.

15.

Predicting Future Suicide: Clinician Opinion versus a Standardized Assessment Tool.

Randall JR, Sareen J, Chateau D, Bolton JM.

Suicide Life Threat Behav. 2018 Jun 19. doi: 10.1111/sltb.12481. [Epub ahead of print]

PMID:
29920749
16.

The Validity and Reliability of Screening Measures for Depression and Anxiety Disorders in Inflammatory Bowel Disease.

Bernstein CN, Zhang L, Lix LM, Graff LA, Walker JR, Fisk JD, Patten SB, Hitchon CA, Bolton JM, Sareen J, El-Gabalawy R, Marriott J, Marrie RA; CIHR Team in Defining the Burden and Managing the Effects of Immune-mediated Inflammatory Disease.

Inflamm Bowel Dis. 2018 Apr 13. doi: 10.1093/ibd/izy068. [Epub ahead of print]

PMID:
29668911
17.

Validation of the PHQ-9 for Suicidal Ideation in Persons with Inflammatory Bowel Disease.

Litster B, Bernstein CN, Graff LA, Walker JR, Fisk JD, Patten SB, Bolton JM, Sareen J, El-Gabalawy R, Marrie RA.

Inflamm Bowel Dis. 2018 Jul 12;24(8):1641-1648. doi: 10.1093/ibd/izy032.

PMID:
29522100
18.

Increased Burden of Psychiatric Disorders in Rheumatoid Arthritis.

Marrie RA, Hitchon CA, Walld R, Patten SB, Bolton JM, Sareen J, Walker JR, Singer A, Lix LM, El-Gabalawy R, Katz A, Fisk JD, Bernstein CN; Canadian Institutes of Health Research Team in Defining the Burden and Managing the Effects of Psychiatric Comorbidity in Chronic Immunoinflammatory Disease.

Arthritis Care Res (Hoboken). 2018 Jul;70(7):970-978. doi: 10.1002/acr.23539. Epub 2018 May 21.

19.

Physical comorbidities increase the risk of psychiatric comorbidity in immune-mediated inflammatory disease.

Marrie RA, Walld R, Bolton JM, Sareen J, Walker JR, Patten SB, Singer A, Lix LM, Hitchon CA, El-Gabalawy R, Katz A, Fisk JD, Bernstein CN; CIHR Team in Defining the Burden and Managing the Effects of Psychiatric Comorbidity in Chronic Immunoinflammatory Disease.

Gen Hosp Psychiatry. 2018 Mar - Apr;51:71-78. doi: 10.1016/j.genhosppsych.2018.01.003. Epub 2018 Jan 11.

PMID:
29353127
20.

The validity and reliability of screening measures for depression and anxiety disorders in multiple sclerosis.

Marrie RA, Zhang L, Lix LM, Graff LA, Walker JR, Fisk JD, Patten SB, Hitchon CA, Bolton JM, Sareen J, El-Gabalawy R, Marriott JJ, Bernstein CN.

Mult Scler Relat Disord. 2018 Feb;20:9-15. doi: 10.1016/j.msard.2017.12.007. Epub 2017 Dec 16.

21.

Estimating annual prevalence of depression and anxiety disorder in multiple sclerosis using administrative data.

Marrie RA, Walld R, Bolton JM, Sareen J, Walker JR, Patten SB, Singer A, Lix LM, Hitchon CA, El-Gabalawy R, Katz A, Fisk JD, Bernstein CN; CIHR Team in Defining the Burden and Managing the Effects of Psychiatric Comorbidity in Chronic Immunoinflammatory Disease.

BMC Res Notes. 2017 Nov 25;10(1):619. doi: 10.1186/s13104-017-2958-1.

22.

Rising incidence of psychiatric disorders before diagnosis of immune-mediated inflammatory disease.

Marrie RA, Walld R, Bolton JM, Sareen J, Walker JR, Patten SB, Singer A, Lix LM, Hitchon CA, El-Gabalawy R, Katz A, Fisk JD, Bernstein CN; CIHR Team in Defining the Burden and Managing the Effects of Psychiatric Comorbidity in Chronic Immunoinflammatory Disease.

Epidemiol Psychiatr Sci. 2019 Jun;28(3):333-342. doi: 10.1017/S2045796017000579. Epub 2017 Nov 3.

PMID:
29098977
23.

Increased incidence of psychiatric disorders in immune-mediated inflammatory disease.

Marrie RA, Walld R, Bolton JM, Sareen J, Walker JR, Patten SB, Singer A, Lix LM, Hitchon CA, El-Gabalawy R, Katz A, Fisk JD, Bernstein CN; CIHR Team in Defining the Burden and Managing the Effects of Psychiatric Comorbidity in Chronic Immunoinflammatory Disease.

J Psychosom Res. 2017 Oct;101:17-23. doi: 10.1016/j.jpsychores.2017.07.015. Epub 2017 Aug 1.

24.

Effect of Housing First on Suicidal Behaviour: A Randomised Controlled Trial of Homeless Adults with Mental Disorders.

Aquin JP, Roos LE, Distasio J, Katz LY, Bourque J, Bolton JM, Bolton SL, Wong JY, Chateau D, Somers JM, Enns MW, Hwang SW, Frankish JC, Sareen J; At Home/Chez Soi Investigators.

Can J Psychiatry. 2017 Jul;62(7):473-481. doi: 10.1177/0706743717694836. Epub 2017 Jan 1.

25.

Increasing medication adherence and income assistance access for first-episode psychosis patients.

Randall J, Chateau D, Bolton JM, Smith M, Katz L, Burland E, Taylor C, Nickel NC, Enns J, Katz A, Brownell M; PATHS Equity Team.

PLoS One. 2017 Jun 7;12(6):e0179089. doi: 10.1371/journal.pone.0179089. eCollection 2017.

26.

Predicting suicide with the SAD PERSONS scale.

Katz C, Randall JR, Sareen J, Chateau D, Walld R, Leslie WD, Wang J, Bolton JM.

Depress Anxiety. 2017 Sep;34(9):809-816. doi: 10.1002/da.22632. Epub 2017 May 4.

PMID:
28471534
27.

Consequences of Sibling Death: Problematic, Potentially Predictable, and Poorly Managed.

Bolton JM, Spiwak R, Sareen J.

JAMA Pediatr. 2017 Jun 1;171(6):519-520. doi: 10.1001/jamapediatrics.2017.0330. No abstract available.

PMID:
28437519
28.

Association of Mental Disorders and Related Medication Use With Risk for Major Osteoporotic Fractures.

Bolton JM, Morin SN, Majumdar SR, Sareen J, Lix LM, Johansson H, Odén A, McCloskey EV, Kanis JA, Leslie WD.

JAMA Psychiatry. 2017 Jun 1;74(6):641-648. doi: 10.1001/jamapsychiatry.2017.0449.

29.

Association Between Spousal Suicide and Mental, Physical, and Social Health Outcomes: A Longitudinal and Nationwide Register-Based Study.

Erlangsen A, Runeson B, Bolton JM, Wilcox HC, Forman JL, Krogh J, Shear MK, Nordentoft M, Conwell Y.

JAMA Psychiatry. 2017 May 1;74(5):456-464. doi: 10.1001/jamapsychiatry.2017.0226.

30.

Emergency department and inpatient coding for self-harm and suicide attempts: Validation using clinician assessment data.

Randall JR, Roos LL, Lix LM, Katz LY, Bolton JM.

Int J Methods Psychiatr Res. 2017 Sep;26(3). doi: 10.1002/mpr.1559. Epub 2017 Feb 24.

PMID:
28233360
31.

A Multimodal Intervention for Children with ADHD Reduces Inequity in Health and Education Outcomes.

Enns JE, Randall JR, Smith M, Chateau D, Taylor C, Brownell M, Bolton JM, Burland E, Katz A, Katz LY, Nickel NC.

Can J Psychiatry. 2017 Jun;62(6):403-412. doi: 10.1177/0706743717692301. Epub 2017 Feb 1.

32.

Screening Tools for Anxiety in People with Multiple Sclerosis: A Systematic Review.

Litster B, Fiest KM, Patten SB, Fisk JD, Walker JR, Graff LA, Bolton JM, Sareen J, Marriott JJ, Berrigan LI, Bernstein CN, Zarychanski R, Singer A, Hitchon CA, Peschken CA, Marrie RA; CIHR Team “Defining the Burden and Managing the Effects of Psychiatric Comorbidity in Chronic Immunoinflammatory Disease”.

Int J MS Care. 2016 Nov-Dec;18(6):273-281. doi: 10.7224/1537-2073.2016-004.

33.

Performance of administrative case definitions for depression and anxiety in inflammatory bowel disease.

Marrie RA, Walker JR, Graff LA, Lix LM, Bolton JM, Nugent Z, Targownik LE, Bernstein CN; CIHR Team “Defining the burden and managing the effects of psychiatric comorbidity in chronic immunoinflammatory disease”.

J Psychosom Res. 2016 Oct;89:107-13. doi: 10.1016/j.jpsychores.2016.08.014. Epub 2016 Sep 3.

PMID:
27663119
34.

A comparison of methods of self-harm without intent to die: Cutting versus self-poisoning.

Chartrand H, Kim H, Sareen J, Mahmoudi M, Bolton JM.

J Affect Disord. 2016 Nov 15;205:200-206. doi: 10.1016/j.jad.2016.07.009. Epub 2016 Jul 5.

PMID:
27449552
35.

Sustained Use of Benzodiazepines and Escalation to High Doses in a Canadian Population.

Alessi-Severini S, Bolton JM, Enns MW, Dahl ME, Chateau D, Collins DM, Sareen J.

Psychiatr Serv. 2016 Sep 1;67(9):1012-8. doi: 10.1176/appi.ps.201500380. Epub 2016 May 2.

PMID:
27133727
36.

Systematic review and meta-analysis of interventions for depression and anxiety in persons with multiple sclerosis.

Fiest KM, Walker JR, Bernstein CN, Graff LA, Zarychanski R, Abou-Setta AM, Patten SB, Sareen J, Bolton JM, Marriott JJ, Fisk JD, Singer A, Marrie RA; CIHR Team Defining the Burden and Managing the Effects of Psychiatric Comorbidity in Chronic Immunoinflammatory Disease.

Mult Scler Relat Disord. 2016 Jan;5:12-26. doi: 10.1016/j.msard.2015.10.004. Epub 2015 Oct 19. Review.

37.

Bereavement after sibling death: a population-based longitudinal case-control study.

Bolton JM, Au W, Chateau D, Walld R, Leslie WD, Enns J, Martens PJ, Katz LY, Logsetty S, Sareen J.

World Psychiatry. 2016 Feb;15(1):59-66. doi: 10.1002/wps.20293.

38.

Authors' reply to Large.

Bolton JM, Gunnell D, Turecki G.

BMJ. 2016 Jan 20;532:i268. doi: 10.1136/bmj.i268. No abstract available.

PMID:
26792533
39.

Development and validation of a risk prediction algorithm for the recurrence of suicidal ideation among general population with low mood.

Liu Y, Sareen J, Bolton JM, Wang JL.

J Affect Disord. 2016 Mar 15;193:11-7. doi: 10.1016/j.jad.2015.12.072. Epub 2015 Dec 31.

PMID:
26766029
40.

Population trends in substances used in deliberate self-poisoning leading to intensive care unit admissions from 2000 to 2010.

Bhaskaran J, Johnson E, Bolton JM, Randall JR, Mota N, Katz C, Rigatto C, Skakum K, Roberts D, Sareen J.

J Clin Psychiatry. 2015 Dec;76(12):e1583-9. doi: 10.4088/JCP.14m09568.

PMID:
26717534
41.

Outcomes in Adult Survivors of Childhood Burn Injuries as Compared with Matched Controls.

Stone J, Gawaziuk JP, Khan S, Chateau D, Bolton JM, Sareen J, Enns J, Doupe M, Brownell M, Logsetty S.

J Burn Care Res. 2016 Mar-Apr;37(2):e166-73. doi: 10.1097/BCR.0000000000000323.

PMID:
26594866
42.

Suicide risk assessment and intervention in people with mental illness.

Bolton JM, Gunnell D, Turecki G.

BMJ. 2015 Nov 9;351:h4978. doi: 10.1136/bmj.h4978. Review.

PMID:
26552947
43.

Mental and Physical Health Outcomes in Parents of Children with Burn Injuries as Compared with Matched Controls.

Enns J, Gawaziuk JP, Khan S, Chateau D, Bolton JM, Sareen J, Stone J, Doupe M, Logsetty S.

J Burn Care Res. 2016 Jan-Feb;37(1):e18-26. doi: 10.1097/BCR.0000000000000309.

PMID:
26361326
44.

Correlates of Nonsuicidal Self-Injury and Suicide Attempts Among Tertiary Care, Emergency Department Patients.

Chartrand H, Bhaskaran J, Sareen J, Katz LY, Bolton JM.

Can J Psychiatry. 2015 Jun;60(6):276-83.

45.

Predictors of Future Suicide Attempts Among Individuals Referred to Psychiatric Services in the Emergency Department: A Longitudinal Study.

Wang Y, Bhaskaran J, Sareen J, Wang J, Spiwak R, Bolton JM.

J Nerv Ment Dis. 2015 Jul;203(7):507-13. doi: 10.1097/NMD.0000000000000320.

PMID:
26053262
46.

Acute risk of suicide and suicide attempts associated with recent diagnosis of mental disorders: a population-based, propensity score-matched analysis.

Randall JR, Walld R, Finlayson G, Sareen J, Martens PJ, Bolton JM.

Can J Psychiatry. 2014 Oct;59(10):531-8.

47.

A population-based longitudinal study of recent stressful life events as risk factors for suicidal behavior in major depressive disorder.

Wang Y, Sareen J, Afifi TO, Bolton SL, Johnson EA, Bolton JM.

Arch Suicide Res. 2015;19(2):202-17. doi: 10.1080/13811118.2014.957448.

PMID:
25559346
48.

Martens et al. respond.

Martens PJ, Chateau DG, Burland EM, Finlayson GS, Smith MJ, Taylor CR, Brownell MD, Nickel NC, Katz A, Bolton JM; PATHS Equity Team.

Am J Public Health. 2015 Feb;105(2):e2. doi: 10.2105/AJPH.2014.302460. No abstract available.

49.

Use of benzodiazepines and related drugs in Manitoba: a population-based study.

Alessi-Severini S, Bolton JM, Enns MW, Dahl M, Collins DM, Chateau D, Sareen J.

CMAJ Open. 2014 Oct 1;2(4):E208-16. doi: 10.9778/cmajo.20130076. eCollection 2014 Oct.

50.

Suicide risk assessment in the emergency department: out of the darkness.

Bolton JM.

Depress Anxiety. 2015 Feb;32(2):73-5. doi: 10.1002/da.22320. Epub 2014 Nov 24. No abstract available.

PMID:
25421638

Supplemental Content

Loading ...
Support Center